- Home
- ALLO vs DNUT Comparison
ALLO vs DNUT Comparison
Compare ALLO & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | DNUT |
|---|---|---|
| Founded | 2017 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 598.2M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALLO | DNUT |
|---|---|---|
| Price | $1.96 | $3.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 5 |
| Target Price | ★ $8.35 | $4.15 |
| AVG Volume (30 Days) | ★ 7.8M | 2.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,522,616,000.00 |
| Revenue This Year | N/A | $0.55 |
| Revenue Next Year | $142,416.42 | $3.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $2.88 |
| 52 Week High | $4.46 | $5.11 |
Technical Indicators
Market Signals| Indicator | ALLO | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 44.13 | 44.48 |
| Support Level | $1.56 | $3.18 |
| Resistance Level | $1.92 | $3.74 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 40.82 | 40.91 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.